Cite

HARVARD Citation

    Cady, R. et al. (2015). A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine. Headache. 55 (1), pp. 101-116. [Online]. 
  
Back to record